9 Results

People

  1. Hassoun
    Hassoun
  2. Lendvai
    Lendvai
  3. Lesokhin
    Lesokhin
  4. Landau
    Landau
  5. Giralt
    Giralt
  6. Landgren
    Landgren
  7. Chung
    Chung
  8. Devlin
    Devlin
  9. Koehne
    Koehne
  10. Korde
    Korde

Groups

  1. Center for Hematologic Malignancies (9)
  2. Department of Medicine (9)
  3. Hematologic Malignancies Research (9)
  4. Hematologic Malignancies, Division of (9)
  5. Myeloma (9)
  6. Bone Marrow Transplant (8)
  7. Survivorship Research (8)
  8. Biostatistics Service (6)
  9. Epidemiology and Biostatistics (6)
  10. Solid Tumor Oncology Division (2)
  1. "Hematologic Malignancies Research"
  2. "Center for Hematologic Malignancies"
  3. "Hani Hassoun"
  4. "Journal article"
  5. "Leukemia and Lymphoma"
Formats
  1. Journal Article (9)
Groups
  1. Center for Hematologic Malignancies (9)
  2. Department of Medicine (9)
  3. Hematologic Malignancies Research (9)
  4. Hematologic Malignancies, Division of (9)
  5. Myeloma (9)
  6. Bone Marrow Transplant (8)

More Groups

People
  1. Alexander Lesokhin (9)
  2. Hani Hassoun (9)
  3. Nikoletta Lendvai (9)
  4. Heather Landau (8)
  5. Carl Landgren (7)
  6. David Chung (7)

More People

Years
  1. 2022 (1)
  2. 2018 (2)
  3. 2017 (4)
  4. 2016 (1)
  5. 2012 (1)
Publications
  1. Leukemia and Lymphoma (9)
Publishers
  1. Taylor & Francis Group (9)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Continuous induction with lenalidomide/dexamethasone versus autologous stem cell transplantation in newly diagnosed multiple myeloma: A case for response-adapted approach
    Journal Article

    Lahoud, O. B.; Landau, H.; Nguyen, J.; Devlin, S.; Lendvai, N.; Weltz, J.; Ayorinde, T.; Chung, D. J.; Lesokhin, A. M.; Kewalramani, T.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity
    Journal Article

    Lendvai, N.; Tsakos, I.; Devlin, S. M.; Schaffer, W. L.; Hassoun, H.; Lesokhin, A. M.; Landau, H.; Korde, N.; Mailankody, S.; Smith, E.; more...
    Leukemia and Lymphoma (2018)

    Fulltext@MSK | Save
  • Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma
    Journal Article

    Pianko, M. J.; Funt, S. A.; Page, D. B.; Cattry, D.; Scott, E. C.; Ansell, S. M.; Borrello, I. M.; Gutierrez, M.; Lendvai, N.; Hassoun, H.; more...
    Leukemia and Lymphoma (2018)

    Fulltext@MSK | Save
  • Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenance
    Journal Article

    Hassoun, H.; Roshal, M.; Sabari, J.; Nguyen, J.; Gao, Q.; Devlin, S. M.; Landau, H.; Lendvai, N.; Chung, D. J.; Lesokhin, A. M.; more...
    Leukemia and Lymphoma (2017)

    Fulltext@MSK | Save
  • Proteomic profiling in plasma cell disorders: A feasibility study
    Journal Article

    Mailankody, S.; Devlin, S. M.; Korde, N.; Lendvai, N.; Lesokhin, A.; Landau, H.; Hassoun, H.; Ballagi, A.; Ekman, D.; Chung, D. J.; more...
    Leukemia and Lymphoma (2017)

    Fulltext@MSK | Save
  • Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation
    Journal Article

    Shah, G. L.; Landau, H.; Londono, D.; Devlin, S. M.; Kosuri, S.; Lesokhin, A. M.; Lendvai, N.; Hassoun, H.; Chung, D. J.; Koehne, G.; more...
    Leukemia and Lymphoma (2017)

    Fulltext@MSK | Save
  • Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: Efficacy and analysis of risk factors associated with poor stem cell collection efficiency*
    Journal Article

    Ogunniyi, A.; Rodriguez, M.; Devlin, S.; Adel, N.; Landau, H.; Chung, D. J.; Lendvai, N.; Lesokhin, A.; Koehne, G.; Mailankody, S.; more...
    Leukemia and Lymphoma (2017)

    Fulltext@MSK | Save
  • Fractionated stem cell infusions for patients with plasma cell myeloma undergoing autologous hematopoietic cell transplantation
    Journal Article

    Landau, H.; Wood, K.; Chung, D. J.; Koehne, G.; Lendvai, N.; Hassoun, H.; Lesokhin, A.; Hoover, E.; Zheng, J. T.; Devlin, S. M.; more...
    Leukemia and Lymphoma (2016)

    Fulltext@MSK | Save
  • Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myeloma with Internatinal Staging System stage II or III, or extramedullary disease
    Journal Article

    Landau, H.; Pandit-Taskar, N.; Hassoun, H.; Cohen, A.; Lesokhin, A.; Lendvai, N.; Drullinsky, P.; Schulman, P.; Jhanwar, S.; Hoover, E.; more...
    Leukemia and Lymphoma (2012)

    Fulltext@MSK | Save